Pharma Industry Survey - launch and insights 📊

Tuesday, August 10, 2021 |
BOB.health is a sustainable solution for health and social care staff that democratises shared learning. BOB's free offering is made possible thanks to revenue from sponsored stories - told by health and social care staff - about the use of suppliers' innovative products or services, pathway and service redesign and collaborative working projects. These are vital stories to tell because ultimately, they benefit patients and make the system use limited resources more efficiently. 

So, we're exploring the challenges that NHS suppliers face around the spread and scale of medicines through a series of surveys. To mark the launch of BOB's 2021 Pharma Industry Survey, we're publishing the insights shared in 2020 around the below topics:

 🏆optimal use cases 
 🎯 approaches to adoption
📊commercial focuses and challenges
 💬NHS involvement in spread and scale of medicines

BOB.health 2020 Pharma Industry Survey: the full video 



Want to read the above insights in your own time? Scroll further down the page.

Have your say - take our newly launched (4-min) 2021 Pharma Industry Survey here.

_____________________________________________________________________________________

2020 - break down of the full results

Optimal use cases



Approaches to adoption


Commercial focuses and challenges









NHS involvement in spread and scale of medicines



Respondent context






Have your say - take our newly launched (4-min) 2021 Pharma Industry Survey here


Thanks for reading! Know someone who'd be interested in this blog? Feel free to forward on.
Want to speak to someone from the BOB Squad about profiling the use of your medicine to bring maximum benefit to patients and value to the NHS? Schedule a conversation with us here.





No comments